Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

November 30, 2007

Conditions

Pemphigus Vulgaris

Interventions

DRUG

Enbrel (Etanercept)

Trial Locations (1)

Clinical Unit for Research Trials in Skin, Boston

All Listed Sponsors

collaborator

Brigham and Women's Hospital

OTHER

collaborator

Stanford University

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00135720 - Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris | Biotech Hunter | Biotech Hunter